aneuploidy Venous Thromboembolism Risk Rise Reported in Individuals With Extra Sex Chromosomes Researchers saw a significant uptick in VTE risk in individuals with supernumerary sex chromosome aneuploidies in both the Geisinger MyCode and UK Biobank cohorts. Studies Assess Tumor Aneuploidy to Guide Immunotherapy Treatment Results from two new studies suggest that tumor aneuploidy can provide an additional layer of information to help predict response to checkpoint blockade immunotherapy. Nanopore Sequencing Assay Enables Rapid Fetal Aneuploidy Detection Premium Researchers at Columbia University Irving Medical Center have developed a test that can detect aneuploidy in different types of reproductive samples within hours. Devyser's Fetal Test Gains IVDR Certification Devyser's QF-PCR-based test can be used by clinicians to detect aneuploidy in fetal cells circulating in maternal blood, amniotic fluid, and chorionic villus biopsy samples. Low, Medium Levels of Mosaic Aneuploidy Among Embryos Don't Affect Birth Rates, Study Finds An Igenomix-led team finds that low- or medium-grade mosaic embryos have similar birth and miscarriage rates as euploid embryos among IVF patients. Feb 26, 2021 Natera Launches Tumor Genomic Profiling Assay, Expects Reproductive Health to Break Even This Year Premium Feb 25, 2021 Natera Revenues Grow 35 Percent in Q4 Jan 13, 2021 At JPM, Natera CEO Lays Out Growth Potential for NIPT, Transplant, Cancer Testing Dec 1, 2020 UnitedHealthcare to Cover NIPT for Average-Risk Pregnancies Nov 16, 2020 Myriad Genetics Bets Fetal DNA Enrichment Method Will Further Increase Uptake of NIPS Test Premium Nov 6, 2020 Natera Expects Further Growth in NIPT as it Expands Use Cases for Cancer, Transplant Tests Premium Oct 29, 2020 Humana Broadens Coverage of NIPT for Average Risk Pregnancies Oct 26, 2020 Yourgene H1 Revenues Up 5 Percent Sep 21, 2020 Yourgene Inks US Distribution Deal for Chemotoxicity Assay, Other Tests Sep 17, 2020 SVB Leerink Initiates Coverage of Natera With Outperform Rating Aug 17, 2020 ACOG Guidelines Recommend NIPT for All Pregnancies Regardless of Risk Aug 5, 2020 Natera Revenues Climb 16 Percent in Q2 Driven by Reproductive Health Business Jul 28, 2020 Yourgene Health Records £2.3M Net Loss for Fiscal Year 2020 Jul 13, 2020 Thermo Fisher Scientific, First Genetics to Develop NGS-Based Diagnostics in Russia Jul 9, 2020 Aneuploidy Common in Early-Stage Human Embryos, Single-Cell RNA-Seq Study Reveals Jul 7, 2020 Progenity Asks Court to Declare Non-Infringement of Natera Patents Jun 3, 2020 Sperm Single-Cell Sequencing Study Offers Insight Into Meiotic Variation May 12, 2020 Natera and Illumina Settle Patent Suit, Sign License Agreement, Amend Supply Deal May 6, 2020 Natera Q1 Revenues Grow 41 Percent Apr 20, 2020 Yourgene Health Fiscal 2020 Revenues Up 86 Percent Load More Breaking News Compact Gene Editing Enzyme May Improve Success Rates of Gene Therapies People in the News at Veracyte, Invitae, Mount Sinai, InterVenn Biosciences, Applied BioCode, More New Products Posted to GenomeWeb: Qiagen, IDT, Revvity, Mission Bio, NRichDx, More FDA Releases Proposed Rule for Oversight of Laboratory-Developed Tests CStone Pharmaceuticals, Genetron Companion Diagnostic Receives NMPA Approval The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.